Unknown

Dataset Information

0

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits.


ABSTRACT: Increasing levels of plasma urotensin II (UII) are positively associated with atherosclerosis. In this study we investigated the role of macrophage-secreted UII in atherosclerosis progression, and evaluated the therapeutic value of urantide, a potent competitive UII receptor antagonist, in atherosclerosis treatment. Macrophage-specific human UII-transgenic rabbits and their nontransgenic littermates were fed a high cholesterol diet for 16 weeks to induce atherosclerosis. Immunohistochemical staining of the cellular components (macrophages and smooth muscle cells) of aortic atherosclerotic lesions revealed a significant increase (52%) in the macrophage-positive area in only male transgenic rabbits compared with that in the nontransgenic littermates. However, both male and female transgenic rabbits showed a significant decrease (45% in males and 31% in females) in the smooth muscle cell-positive area compared with that of their control littermates. The effects of macrophage-secreted UII on the plaque cellular components were independent of plasma lipid level. Meanwhile the wild-type rabbits were continuously subcutaneously infused with urantide (5.4?µg·?kg-1·?h-1) using osmotic mini-pumps. Infusion of urantide exerted effects opposite to those caused by UII, as it significantly decreased the macrophage-positive area in male wild-type rabbits compared with that of control rabbits. In cultured human umbilical vein endothelial cells, treatment with UII dose-dependently increased the expression of the adhesion molecules VCAM-1 and ICAM-1, and this effect was partially reversed by urantide. The current study provides direct evidence that macrophage-secreted UII plays a key role in atherogenesis. Targeting UII with urantide may promote plaque stability by decreasing macrophage-derived foam cell formation, which is an indicator of unstable plaque.

SUBMITTER: Yu QQ 

PROVIDER: S-EPMC7468446 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits.

Yu Qing-Qing QQ   Cheng Da-Xin DX   Xu Li-Ran LR   Li Yan-Kui YK   Zheng Xiao-Ya XY   Liu Yi Y   Li Ya-Feng YF   Liu Hao-le HL   Bai Liang L   Wang Rong R   Fan Jiang-Lin JL   Liu En-Qi EQ   Zhao Si-Hai SH  

Acta pharmacologica Sinica 20191104 4


Increasing levels of plasma urotensin II (UII) are positively associated with atherosclerosis. In this study we investigated the role of macrophage-secreted UII in atherosclerosis progression, and evaluated the therapeutic value of urantide, a potent competitive UII receptor antagonist, in atherosclerosis treatment. Macrophage-specific human UII-transgenic rabbits and their nontransgenic littermates were fed a high cholesterol diet for 16 weeks to induce atherosclerosis. Immunohistochemical stai  ...[more]

Similar Datasets

| S-EPMC9963243 | biostudies-literature
| S-EPMC3991611 | biostudies-other
| S-EPMC6958682 | biostudies-literature
| S-EPMC3885346 | biostudies-literature
| S-EPMC8589160 | biostudies-literature
| S-EPMC10062573 | biostudies-literature
| S-EPMC5645213 | biostudies-literature
| S-EPMC7429960 | biostudies-literature
| S-EPMC2884639 | biostudies-literature
| S-EPMC5480870 | biostudies-literature